Clinical implication of genetic composition and molecular mechanism on treatment strategies of HER2-positive breast cancers

The current clinical management model of HER2-positive breast cancers is commonly based on guidelines, which in turn are based on the design and outcome of clinical trials. While this model is useful to most practicing clinicians, the treatment outcome of individual patient is not certain at the sta...

Descripción completa

Detalles Bibliográficos
Autores principales: Chow, Christopher Y.C., Lie, Erich Ferdiansyah, Wu, Cheng-Hsun, Chow, Louis W.C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659858/
https://www.ncbi.nlm.nih.gov/pubmed/36387174
http://dx.doi.org/10.3389/fonc.2022.964824

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659858/
https://www.ncbi.nlm.nih.gov/pubmed/36387174
http://dx.doi.org/10.3389/fonc.2022.964824

Ejemplares similares